Ellen O'Connor Vos Optimize Rx Corp (OPRX) insider trading activity

Ellen O'Connor Vos is Director of OptimizeRx Corp. Currently has a direct ownership of 62,774 shares of OPRX, which is worth approximately $308,220. The most recent transaction as insider was on Jun 07, 2024, when has been sold 13,286 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 62.8K

0% 3M change

59.22% 12M change

Total Value Held $308,220

Ellen O'Connor Vos Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 07 2024	BUY Grant, award, or other acquisition	-	13,286 Added 17.47%	62,774 Common Stock
Jun 05 2024	BUY Exercise of conversion of derivative security	-	10,061 Added 16.9%	49,488 Common Stock
Jun 07 2023	BUY Exercise of conversion of derivative security	-	4,637 Added 10.52%	39,427 Common Stock
Mar 31 2023	BUY Exercise of conversion of derivative security	-	657 Added 1.85%	34,790 Common Stock
Dec 30 2022	BUY Exercise of conversion of derivative security	-	409 Added 1.18%	34,133 Common Stock
Sep 29 2022	BUY Exercise of conversion of derivative security	-	334 Added 0.98%	33,724 Common Stock
Aug 16 2022	BUY Open market or private purchase	$7,955 $15.91 p/Share	500 Added 50.0%	500 Common Stock
Jun 30 2021	BUY Grant, award, or other acquisition	-	407 Added 1.22%	32,890 Common Stock
Mar 31 2021	BUY Grant, award, or other acquisition	-	539 Added 1.63%	32,483 Common Stock
Dec 31 2020	BUY Grant, award, or other acquisition	-	802 Added 2.45%	31,944 Common Stock
Sep 30 2020	BUY Grant, award, or other acquisition	-	1,183 Added 3.66%	31,142 Common Stock

Also insider at

MODD

Modular Medical, Inc. Healthcare

Director

AWH

Aspira Women's Health Inc. Healthcare

EOV